S&P Pharmaceuticals SPDR (XPH)
39.50 x 1 45.54 x 6
Post-market by (Cboe BZX)
42.30 -0.45 (-1.05%) 03/28/25 [NYSE Arca]
39.50 x 1 45.54 x 6
Post-market 42.40 +0.10 (+0.24%) 16:23 ET
for Fri, Mar 28th, 2025
Results
download Want to compare other data? Select Fields| Symbol | XPH | VHT | IBB | ||
| Company | S&P Pharmaceuticals SPDR | Healthcare ETF Vanguard | Nasdaq Biotechnology Ishares ETF | ||
| Price Information | |||||
| Exchange | NYSE Arca | NYSE Arca | NASDAQ | ||
| Open | 42.79 | 264.06 | 131.42 | ||
| High | 42.79 | 264.38 | 131.85 | ||
| Low | 42.21 | 262.65 | 129.97 | ||
| Last | 42.30 | 262.90 | 130.29 | ||
| Change | -0.45 | -1.25 | -1.29 | ||
| % Change | -1.05% | -0.47% | -0.98% | ||
| Volume | 15,000 | 256,300 | 1,278,000 | ||
| 20-Day Average Volume | 75,840 | 180,415 | 1,099,225 | ||
| Previous Close | 42.75 | 264.15 | 131.58 | ||
| Industry | N/A | N/A | Finance - Investment Funds | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 43.54 | 267.08 | 134.12 | ||
| 20-Day Raw Stochastic | 3.36% | 15.33% | 3.85% | ||
| 20-Day Relative Strength | 38.86% | 43.74% | 40.44% | ||
| Weighted Alpha | -0.94 | -1.43 | -5.34 | ||
| Today's Opinion | 72% Sell | 72% Sell | 100% Sell | ||
| Previous Opinion | 72% Sell | 72% Sell | 100% Sell | ||
| Last Month's Opinion | 16% Sell | 24% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.93% since 03/21/25 | -1.51% since 03/21/25 | -2.46% since 03/21/25 | ||
| Low | 42.21 on 03/28/25 | 262.65 on 03/28/25 | 129.97 on 03/28/25 | ||
| High | 44.34 on 03/24/25 | 269.86 on 03/24/25 | 135.67 on 03/24/25 | ||
| 1-Month | |||||
| %Chg | -5.07% since 02/28/25 | -3.29% since 02/28/25 | -4.92% since 02/28/25 | ||
| Low | 42.21 on 03/28/25 | 260.94 on 03/13/25 | 129.97 on 03/28/25 | ||
| High | 44.89 on 03/03/25 | 273.72 on 03/03/25 | 138.29 on 03/07/25 | ||
| 3-Month | |||||
| %Chg | -2.74% since 12/27/24 | +2.54% since 12/27/24 | -2.42% since 12/27/24 | ||
| Low | 42.21 on 03/28/25 | 252.13 on 12/30/24 | 129.97 on 03/28/25 | ||
| High | 46.07 on 01/30/25 | 274.19 on 02/05/25 | 142.80 on 02/06/25 | ||
| 6-Month | |||||
| %Chg | -3.60% since 09/27/24 | -6.20% since 09/27/24 | -10.08% since 09/27/24 | ||
| Low | 42.21 on 03/28/25 | 250.07 on 12/19/24 | 129.61 on 12/19/24 | ||
| High | 48.76 on 11/11/24 | 283.73 on 10/14/24 | 150.04 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 166,913 | 16,469,685 | 6,156,202 | ||
| Shares Outstanding, K | 3,900 | 62,349 | 47,250 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | 0 | 0 | 0 | ||
| Last Quarter Sales | N/A | N/A | N/A | ||
| Last Quarter Net Income | N/A | N/A | N/A | ||
| 60-Month Beta | 0.84 | 0.73 | 0.84 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | N/A | ||
| Latest Earnings Date | N/A | N/A | N/A | ||
| Most Recent Dividend | 0.153 on 03/24/25 | 0.940 on 03/25/25 | 0.121 on 03/18/25 | ||
| Next Ex-Dividends Date | 03/24/25 | 03/25/25 | 03/18/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 10.54 | 22.00 | 15.68 | ||